» Articles » PMID: 32576255

Natural Dietary Compound Naringin Inhibits Glioblastoma Cancer Neoangiogenesis

Overview
Publisher Biomed Central
Specialty Pharmacology
Date 2020 Jun 25
PMID 32576255
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Flavonoids, which existed nearly in all fruits and vegetables, are considered as a class of plant-secondary metabolites with a polyphenolic structure and have properties with health-improving potential. Yet, not so many experimental focus on the benefits of flavonoid in vivo after external application. Here we assessed the impacts of naringin in vitro and in vivo in the human glioma U-87 cells implanted into athymic mice.

Methods: Tumor size and animal survival time were followed in naringin-treated mice bearing subcutaneous gliomas. To define the effects of naringin on angiogenesis, in vitro, tube formation and migration were assayed using endothelial HUVEC cell line.

Results: Low concentration of naringin remarkably inhibited tubulogenesis and reduced cell invasion. Moreover, naringin has been shown to have a toxicity effect on U-87 cells in a dose-dependent way. Furthermore, naringin administration (120 mg/kg/day) applies serious anti-cancer belongings on glioblastoma, as demonstrated by a slow cancer progression.

Conclusions: Our study has provided the first evidence on the antitumor effect of naringin, which is somehow due to the inhibition of invasion and angiogenesis.

Citing Articles

Functionalization of Polyvinylpyrrolidone Films by Grafting Maleic Acid from PVP Gels for Loading Studies of Naringin and Silver Nanoparticles as Potential Wound Dressings.

Perez-Garibay M, Lara-Rodriguez G, Bucio E Gels. 2025; 11(2).

PMID: 39996689 PMC: 11855149. DOI: 10.3390/gels11020147.


Phyto-chemistry and Therapeutic Potential of Natural Flavonoid Naringin: A Consolidated Review.

Anush Sheikh K, Haokip S, Hazarika B, Devi O, Lian H, Yumkhaibam T Chin J Integr Med. 2025; .

PMID: 39994136 DOI: 10.1007/s11655-025-3826-9.


Systematic Review of Pre-Clinical Systems Using Artificial Microenvironments and Anti-Migratory Drugs to Control Migration of Glioblastoma Cells.

Selvi H, Bruning-Richardson A, Danovi D Expert Rev Mol Med. 2025; 27:e6.

PMID: 39844377 PMC: 11803519. DOI: 10.1017/erm.2024.33.


Steady-State Delivery and Chemical Modification of Food Nutrients to Improve Cancer Intervention Ability.

Hao S, Ge P, Su W, Wang Y, Abd El-Aty A, Tan M Foods. 2024; 13(9).

PMID: 38731734 PMC: 11083276. DOI: 10.3390/foods13091363.


Promotion of ROS-mediated apoptosis, G2/M arrest, and autophagy by naringenin in non-small cell lung cancer.

Chang T, Chi M, Chiang Y, Lin C, Fang M, Lee C Int J Biol Sci. 2024; 20(3):1093-1109.

PMID: 38322119 PMC: 10845293. DOI: 10.7150/ijbs.85443.


References
1.
Salehi B, Tsouh Fokou P, Sharifi-Rad M, Zucca P, Pezzani R, Martins N . The Therapeutic Potential of Naringenin: A Review of Clinical Trials. Pharmaceuticals (Basel). 2019; 12(1). PMC: 6469163. DOI: 10.3390/ph12010011. View

2.
Zhang Y, Li Y, Wang Y, Sun S, Jiang T, Li C . Naringin, a natural dietary compound, prevents intestinal tumorigenesis in Apc (Min/+) mouse model. J Cancer Res Clin Oncol. 2015; 142(5):913-25. DOI: 10.1007/s00432-015-2097-9. View

3.
Ming H, Chuang Q, Jiashi W, Bin L, Guangbin W, Xianglu J . Naringin targets Zeb1 to suppress osteosarcoma cell proliferation and metastasis. Aging (Albany NY). 2018; 10(12):4141-4151. PMC: 6326679. DOI: 10.18632/aging.101710. View

4.
Li H, Yang B, Huang J, Xiang T, Yin X, Wan J . Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway. Toxicol Lett. 2013; 220(3):219-28. DOI: 10.1016/j.toxlet.2013.05.006. View

5.
Kim C, Joe Y, Lee S, Kim E, O E, Kim H . Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model. Cancer Lett. 2009; 288(2):251-60. DOI: 10.1016/j.canlet.2009.07.008. View